CVACE protocol

chemotherapy protocol consisting of above compounds; used in the treatment of small cell carcinoma of lung & neuroblastoma

Also Known As:

COPE protocol; N6 protocol

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Therapy Context: Research Results

Therapeutics: 1158551
- Drug Therapy: 293145
  - Combination Drug Therapy: 12066
    - Antineoplastic Combined Chemotherapy Protocols: 35
      - CVACE protocol: 2
  - Antineoplastic Protocols: 55
    - Antineoplastic Combined Chemotherapy Protocols: 35
      - CVACE protocol: 2
- Clinical Protocols
  - Antineoplastic Protocols: 55
    - Antineoplastic Combined Chemotherapy Protocols: 35
      - CVACE protocol: 2
Inorganic Chemicals: 9
Organic Chemicals: 133
- Hydrocarbons: 1713
  - Cyclic Hydrocarbons: 97
    - Aromatic Hydrocarbons: 291
      - Polycyclic Aromatic Hydrocarbons: 2020
        Naphthalenes: 18
        Tetrahydronaphthalenes: 1
        Podophyllotoxin: 562
        Etoposide: 10706
        CVACE protocol: 2
        Naphthacenes
        Anthracyclines: 9423
        Daunorubicin: 2641
        Doxorubicin: 35390
        CVACE protocol: 2
  - Halogenated Hydrocarbons: 42
    - Mustard Compounds: 3
      - Nitrogen Mustard Compounds: 2
        Phosphoramide Mustards: 5
        Cyclophosphamide: 25473
        CVACE protocol: 2
- Organophosphorus Compounds: 300
  - Phosphoramides: 8
    - Phosphoramide Mustards: 5
      - Cyclophosphamide: 25473
        CVACE protocol: 2
Polycyclic Compounds: 6
- Polycyclic Aromatic Hydrocarbons: 2020
  - Naphthalenes: 18
    - Tetrahydronaphthalenes: 1
      - Podophyllotoxin: 562
        Etoposide: 10706
        CVACE protocol: 2
  - Naphthacenes
    - Anthracyclines: 9423
      - Daunorubicin: 2641
        Doxorubicin: 35390
        CVACE protocol: 2
Carbohydrates: 22023
- Glycosides: 2119
  - Aminoglycosides: 5131
    - Anthracyclines: 9423
      - Daunorubicin: 2641
        Doxorubicin: 35390
        CVACE protocol: 2
  - Glucosides: 639
    - Etoposide: 10706
      - CVACE protocol: 2
Heterocyclic Compounds: 198
- Alkaloids: 5398
  - Indole Alkaloids: 200
    - Secologanin Tryptamine Alkaloids: 81
      - Vinca Alkaloids: 463
        Vincristine: 9251
        CVACE protocol: 2
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Indoles: 200
      - Indole Alkaloids: 200
        Secologanin Tryptamine Alkaloids: 81
        Vinca Alkaloids: 463
        Vincristine: 9251
        CVACE protocol: 2
    - Indolizines: 3
      - Indolizidines: 2
        Indole Alkaloids: 200
        Secologanin Tryptamine Alkaloids: 81
        Vinca Alkaloids: 463
        Vincristine: 9251
        CVACE protocol: 2

Experts

1.	Keeling, Sally: 1 article (07/2006)
2.	Roud, Helen: 1 article (07/2006)
3.	Sainsbury, Richard: 1 article (07/2006)
4.	Abramson, S: 1 article (01/2001)
5.	Byrnes, M: 1 article (01/2001)
6.	Cheung, I Y: 1 article (01/2001)
7.	Cheung, N K: 1 article (01/2001)
8.	Dantis, E: 1 article (01/2001)
9.	Finn, R: 1 article (01/2001)
10.	Gerald, W: 1 article (01/2001)

Related Diseases

1.	Neuroblastoma 01/01/2001 - "The N7 protocol for poor-risk neuroblastoma uses dose-intensive chemotherapy (as in N6 protocol [Kushner et al.: J Clin Oncol 12:2607-2613, 1994] but with lower dosing of vincristine) for induction, surgical resection and 2100 cGy hyperfractionated radiotherapy for local control, and for consolidation, targeted radioimmunotherapy with 131I-labeled anti-GD2 3F8 monoclonal antibody and immunotherapy with unlabeled/unmodified 3F8 (400 mg/m2). "
2.	Dementia (Dementias) 07/07/2006 - "To assess the utility and acceptability of the CI with health practitioners and informal carers of people with dementia, following the European COPE protocol. "

Related Drugs and Biologics

1.	Vincristine (Oncovin)
2.	Monoclonal Antibodies

Related Therapies and Procedures

1.	Radioimmunotherapy
2.	Radiotherapy
3.	Immunotherapy
4.	Drug Therapy (Chemotherapy)